Edisononcology
The startup develops targeted biopharmaceutical therapies that focus on overcoming treatment resistance in cancer patients by leveraging insights from cancer biology to identify effective drug candidates. This approach enhances the availability of suitable therapies, ultimately improving survival outcomes for patients.
Traction –/10
Menlo Park, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops targeted biopharmaceutical therapies that focus on overcoming treatment resistance in cancer patients by leveraging insights from cancer biology to identify effective drug candidates. This approach enhances the availability of suitable therapies, ultimately improving survival outcomes for patients.